| Literature DB >> 27275925 |
Fei Yang1, Huabin Cao1, Qingyang Xiao1, Xiaoquan Guo1, Yu Zhuang1, Caiying Zhang1, Tiancheng Wang1, Huayuan Lin1, Yalu Song1, Guoliang Hu1, Ping Liu1.
Abstract
BACKGROUND: Pulmonary arterial hypertension, also known as Ascites syndrome (AS), remains a clinically challenging disease with a large impact on both humans and broiler chickens. Pulmonary arterial remodeling presents a key step in the development of AS. The precise molecular mechanism of pulmonary artery remodeling regulating AS progression remains unclear. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27275925 PMCID: PMC4898705 DOI: 10.1371/journal.pone.0156045
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of AHI and blood routine in disease and normal groups.
| Project name | Normal group (n = 20) | Disease group (n = 55) | P-value |
|---|---|---|---|
| 0.21±0.01 | 0.27±0.01 | <0.01 | |
| 151.00±5.01 | 200.45±6.33 | <0.01 | |
| 29.75±1.09 | 35.47±1.02 | <0.01 | |
| 104.96±5.59 | 180.50±12.32 | <0.01 | |
| 94.59±4.46 | 140.67±6.76 | <0.01 | |
| 7.04±0.77 | 22.16±2.94 | <0.01 | |
| 30.47±0.41 | 32.50±0.67 | <0.05 |
Note: “n” represents the number of broilers in each group. RV/TV means right ventricular weight/ total ventricular weight; HGB means hemoglobin; HCT means hematocrit; WBC means white blood cell; LYM means lymphocyte; GRNA means Granulocyte ratio; RDW-SD means red blood cell distribution width-standard deviation.
Basic summary of sequence and sequencing reads mapping to reference genome.
| Sample name | N1 | N2 | D1 | D2 |
|---|---|---|---|---|
| 13172095 | 15908860 | 13818353 | 13992954 | |
| 12921832 | 15674675 | 13493794 | 13735361 | |
| 0.65G | 0.78G | 0.67G | 0.69G | |
| 48.61 | 49.01 | 50.26 | 50.42 | |
| 218094(1.69%) | 228240(1.46%) | 210695(1.56%) | 250856(1.83%) | |
| 11469582(88.75%) | 13933328(88.89%) | 11909334(88.26%) | 12064522(87.84%) | |
| 5734482(44.38%) | 6963551(44.43%) | 5955487(44.14%) | 6029451(43.9%) | |
| 5735100(44.38%) | 6969777(44.47%) | 5953847(44.12%) | 6035071(43.94%) | |
| 9790044(75.76%) | 11774512(75.12%) | 10000081(74.11%) | 10074221(73.35%) | |
| 1679538(13%) | 2158816(13.77%) | 1909253(14.15%) | 1990301(14.49%) |
Note: “+” refers to sense strands, “-” indicates anti-sense strands; “non-splice reads” refers to entire sequence is mapped to one exon; “splice reads” refers to reads mapped to the border of exon. “N1, N2” represents normal samples and “D1, D2” represents disease samples.
Fig 1Differential expressed genes filtering.
(A) In the volcano diagram, the significantly up-regulated genes are in red and the down-regulated genes are in green, while no difference is indicated in blue by the standard of p-adjusted< 0.05. (B) A heat map of N and D sample gene expression clustering, with high levels of expression shown in red and low levels shown in blue.
Fig 2GO enrichment analysis of DEGs in the pulmonary artery.
The three main categories used for GO analysis. The y-axis and x-axis indicate subcategory name and gene number, respectively. * represents the significantly enriched GO terms.
Fig 3KEGG enrichment analysis of DEGs in the pulmonary artery.
The most 20 KEGG pathways were presented. The y-axis and x-axis indicate pathway name and rich factor, respectively. The size of circle dot means gene number.
Putative significantly differential expressed molecules and genes enriched to Jak-STAT signaling pathway and NOD-like signaling pathway.
| Signaling molecules | Gene name | Gene ID | Padj | Description |
|---|---|---|---|---|
| IL6 | CSF3 | ENSGALG00000026420 | 0.00010085 | Interleukin-6/Interleukin-23 |
| IL6 | ENSGALG00000010915 | 2.23E-06 | Interleukin-6/Interleukin-23 | |
| CytokineR | IL4RA | ENSGALG00000006313 | 0.02562 | Interleukin-4 receptor alpha |
| IL2RG | ENSGALG00000005638 | 0.0013193 | Interleukin-6 receptor alpha | |
| IL13RA1 | ENSGALG00000006032 | 0.022197 | Interleukin-6 receptor alpha | |
| IL13RA2 | ENSGALG00000020316 | 1.74E-21 | Interleukin-6 receptor alpha | |
| IL12RB1 | ENSGALG00000027301 | 0.028163 | Fibronectin, type III | |
| IL20RA | ENSGALG00000013869 | 4.37E-13 | Interferon alpha/beta receptor | |
| IFNGR1 | ENSGALG00000013865 | 0.012232 | Interferon gamma receptor | |
| IL10R1 | ENSGALG00000024075 | 0.00027589 | Interferon alpha/beta receptor | |
| GP130 | ENSGALG00000014716 | 0.013903 | Immunoglobulin C2-set-like | |
| IL22RA2 | ENSGALG00000013868 | 0.038518 | Interferon alpha/beta receptor | |
| CSF3R | ENSGALG00000002112 | 1.54E-10 | Immunoglobulin C2-set-like, | |
| OSMR | ENSGALG00000003747 | 0.032166 | Fibronectin, type III | |
| IL10R2 | ENSGALG00000015941 | 0.024509 | Interferon alpha/beta receptor, beta | |
| STAT | STAT5 | ENSGALG00000003282 | 0.0077515 | STAT transcription factor |
| STAT3 | ENSGALG00000003267 | 0.00026403 | STAT transcription factor | |
| PI3K | PIK3R5 | ENSGALG00000021573 | 2.22E-05 | Phosphoinositide 3-kinase regulatory subunit 5/6 |
| SOCS | SOCS3 | ENSGALG00000027786 | 4.37E-12 | SOCS protein, |
| SOCS1 | ENSGALG00000007158 | 1.38E-08 | SOCS protein | |
| Pim-1 | PIM1 | ENSGALG00000000742 | 3.42E-05 | Lipopolysaccharide kinase |
| CycD | CCND3 | ENSGALG00000003485 | 0.00056472 | Cyclin A/B/D/E/F |
| IKKγ | CHUK | ENSGALG00000003289 | 0.0019618 | Serine/threonine/dual specificity protein kinase |
| P38 | MAPK11 | ENSGALG00000008612 | 0.0003684 | Mitogen-activated protein (MAP) kinase, p38 |
| IγK | NFKBIA | ENSGALG00000027864 | 0.046652 | Ankyrin repeat-containing domain |
| IL8 | IL8 | ENSGALG00000026098 | 5.93E-47 | Chemokine interleukin-8-like domain |
| K60 | ENSGALG00000011668 | 3.31E-21 | Chemokine interleukin-8-like domain | |
| IL6 | IL6 | ENSGALG00000010915 | 2.23E-06 | Interleukin-6/Interleukin-23 |
| IL1β | IL-1BETA | ENSGALG00000000534 | 1.86E-18 | Interleukin-1 alpha/beta |
| IL18 | IL18 | ENSGALG00000007874 | 0.020274 | Interleukin-18 Interleukin-1 family |
| NOD1 | NOD1 | ENSGALG00000011535 | 0.0077515 | P-loop containing nucleoside triphosphate hydrolase |
| PIP2 | RIPK2 | ENSGALG00000015899 | 0.00045037 | Serine/threonine/dual specificity protein kinase |
| cIAP12 | ITA | ENSGALG00000017186 | 2.53E-09 | Baculoviral inhibition of apoptosis protein repeat |
| A20 | TNFAIP3 | ENSGALG00000013861 | 5.22E-10 | Ovarian tumour, otubain |
| Cardinal | CARD8 | ENSGALG00000007698 | 0.048385 | Death-like /CARD domain |
| HSP90 | HSP90AA1 | ENSGALG00000011351 | 0.049445 | Heat shock protein Hsp90 family |
Note: A gene with a Padj<0.05 is considered as significantly differential expressed. Padj means the corrected-P value.
Other putative significantly differential expressed genes regulating pulmonary artery remodeling and vascular contraction in this study.
| Gene name | Gene ID | Readcount D | Readcount N | Description | Padj |
|---|---|---|---|---|---|
| CYP1B1 | ENSGALG00000025822 | 398.6948 | 1071.227 | Cytochrome P450, E-class, group ICytochrome P450, E-class, group IV | 0.003082 |
| ALDH7A1 | ENSGALG00000008229 | 1946.312 | 856.2167 | Aldehyde/histidinol dehydrogenase||Aldehyde dehydrogenase domain | 0.01793 |
| MYLK | ENSGALG00000011708 | 13269.39 | 40167.41 | Immunoglobulin Serine/threonine/dual specificity protein kinase, catalytic domain | 8.22E-05 |
| CaM | ENSGALG00000010023 | 2193.544 | 4622.791 | EF-hand, Ca insensitive||EF-hand domain | 0.028664 |
| CAMK4 | ENSGALG00000000244 | 12.22596 | 63.68015 | Protein kinase-like domain|| Serine /threonin dual specificity protein kinase | 0.026825 |
| INOS | ENSGALG00000005693 | 8249.399 | 188.7036 | Nitric oxide synthase, N-terminal|| Nitric-oxide synthase, eukaryote | 3.54E-36 |
| BMP7 | ENSGALG00000007668 | 219.6748 | 591.5117 | Cystine-knot cytokine||Transforming growth factor-beta, C-terminal/N-terminal | 0.00706 |
Note: A gene with a Padj<0.05 is considered as significantly differential expressed. Padj means the corrected-P value. Readcount D means the readcounts of disease samples; Readcount N means the readcounts of normal samples.
Fig 4qRT-PCR and sequencing.
qRT-PCR validation of differentially expressed genes in disease and normal samples of pulmonary artery for 12 genes.
Fig 5Observation of pulmonary artery sections (200X, HE) The pulmonary artery wall thickness of disease (D) is noticeably increased. In the D sample, 1) the tunica adventicia was more compact and exhibited increased connective tissue; 2) the smooth muscle fiber was thicker; 3) there was excessive fiber production; and 4) the intima was more compact. The arrows indicate the pathological changes.